Zepbound Sheds More Weight Than Wegovy, Study Finds

Researchers said Lilly’s Zepbound “was associated with significantly greater weight loss” than Novo’s Wegovy, adding that the study is the first to compare the two drugs—marketed for diabetes as Mounjaro and Ozempic—in obese and overweight adults.